About: BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.08 (+16.92%)
BDXASXBcal Diagnostics Ltd
Bcal Diagnostics Ltd share price
BDX price activity
Último preço
$ 0,080
Variação (24h)
0,01 AUD (16,92%)
Volume
180.27K
Volume (média 4 sem.)
-
Abertura
$ 0,07
Variação do dia
$ 0,07 - $ 0,08
Fechamento anterior
$ 0,07
Último negócio
10 Sep, 6:10 am GMT+0
Atrasado
10 Sep, 6:10 am GMT+0
BDX price performance
Atrasado
10 Sep, 6:10 am GMT+0
quote.marketSignals